PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy

<div>Kaplan-Meier survival curves of patients with stage III, IIIB, and IIIC disease receiving oxaliplatin-based chemotherapy. (a) OS in total stage III; (b) OS in stage IIIB; (c) OS in stage IIIC. MST: median survival time.</div>

Mediators of Inflammation

fig3

Figure 3

Figure 3: PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy 